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Bioreductive alkylating agents are an important
class of clinical antitumor antibiotics that cross-
link andmonoalkylate DNA. Here, we use a syn-
thetic, photochemically activated derivative of
FR400482 to investigate the molecular mecha-
nism of this class of drugs in a biologically rele-
vant context. We find that the organization of
DNA into nucleosomes effectively protects it
against drug-mediated crosslinking, while per-
mitting monoalkylation. This modification has
the potential to lead to the formation of covalent
crosslinks between chromatin and nuclear pro-
teins. Using in vitro approaches, we found that
interstrand crosslinking of free DNA results in
a significant decrease in basal and activated
transcription. Finally, crosslinked plasmid DNA
is inefficiently assembled into chromatin. Our
studies suggest pathways for the clinical effec-
tiveness of this class of reagents.
INTRODUCTION
Many anticancer agents act by impeding rapid prolifera-
tion, which is characteristic of cancer cells. While some
impact cytoskeletal dynamics and cell-signaling path-
ways, others affect basic cellular processes such as repli-
cation and transcription. Compounds that fall into the latter
class include interstrand DNA-crosslinking/DNA-alkylat-
ing agents. DNA crosslinking affects DNA-related pro-
cesses specifically via the formation of covalent bonds
betweenbothDNAstrands. This is apotent drug-mediated
modification associated with severe cytotoxicity [1]. The
detailed effects of drug-mediated DNA alkylation on cell
proliferation are yet to be determined, since such lesions
are likely to be removed and repaired via DNA base-
excision repair mechanisms [2, 3].
Bioreductive alkylating agents include families of bi-
functional compounds that are capable of forming mono-
alkylated DNA and interstrand DNA crosslinks under
highly reducing conditions. The specific targeting of theseChemistry & Biology 14,drugs to cancer cells has been rationalized by their ability
to be activated under the hypoxic conditions that prevail
in cancer cells as a result of their high replication rate [4].
A representative clinically significant drug is Mitomycin C
(MMC, 1, Figure 1) [5].MMC is themost thoroughly studied
member of this class of compounds and has been in
clinical use for over 30 years as an antitumor agent [6–8].
FR900482 (2, Figure 1), a natural metabolite obtained
along with FR66979 (3, Figure 1A) from Streptomyces
sandaensis No. 6897, is structurally and functionally re-
lated to MMC [9, 10], but it was dropped from clinical de-
velopment in Phase I studies due to the development of
vascular-leak syndrome in patients.More recently, a semi-
synthetic derivative, FK317, has exhibited promising anti-
tumor activity [10–15] and has advanced from Phase I to
Phase II human clinical trials. FK317 (4, Figure 1A) shares
structural similarities and properties with FR900482 (2,
Figure 1A), but its use led to fewer side effects, particularly
with respect to vascular-leak syndrome, when compared
to FR900482 [11, 16].
MMC can be activated via a one-electron or two-elec-
tron reduction pathway to form a highly reactive bis-elec-
trophilic mitosene species that is capable of both mono-
alkylating and crosslinkingDNA. In contrast, FR900482 and
FK317 are activated specifically by a two-electron reduc-
tion pathway to form a structurally and functionally related
bis-electrophilic mitosene species (8, Figure 1) that is like-
wise capable of monoalkylating (10) and crosslinking DNA
(11). In all three instances, it has been demonstrated that
mitosenes preferentially crosslink B form DNA at 50CpG30
steps in the minor groove [17–19]. Mitosene formation ap-
pears to be the rate-limiting step in the formation of the
final drug-mediated lesion [19]. The solution structure of
monoalkylated DNA indicates that the monoadduct re-
presents an intermediate species in a reaction that results
in the formation of an interstrand-crosslinked product
[20–22]. Recently, we reported a new, to our knowledge,
generation of synthetic mitosene progenitors based on
FR900482 that can be activated with alternative chemical
signals not requiring reductive activation [23]. These
agents can potentially obviate the slow generation of the
mitosene, and they also allow for controlled release of
these highly reactive species. In particular, the totally syn-
thetic NVOC derivative related to FR900482 (5, Figure 1) is553–563, May 2007 ª2007 Elsevier Ltd All rights reserved 553
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The Effects of Alkylating Agents on ChromatinFigure 1. Structure of the Various Mitosene-Based Anticancerous Agents and the Basis for Their Sequence Specificity
(A) Structures of Mitomycin C, FR900482, and congeners. Compound 5 is a photoactivated mitosene progenitor.
(B) Geometrical basis for mitosene-based crosslinking specificity.activated photochemically and exhibits biochemical reac-
tivity similar to FK317 [23], including the characteristic
50CpG30 sequence specificity for interstrand crosslinking.
The striking preference of all mitosene-based drugs for
crosslinking 50CpG30 steps is thought to be due to the
geometrical arrangement of the two electrophilic sites on
the mitosene, which closely aligns with the distance be-
tween the opposing dG residues at a 50CpG30 step in B
form DNA (Figure 1B). This requirement has been shown
to be less stringent for monoalkylation [20, 24]. While the
sequence specificity for both monoalkylation and inter-
strand crosslinking was originally determined on free B
form DNA [25], the interactions of this class of drugs with
DNA in the context of nucleosomes have not been studied
in detail. This is a significant concern since80%of all eu-
karyotic DNA is organized into nucleosomes. Nucleoso-
mal DNA conformation deviates significantly from that of
unassembled B form DNA, and, as such, the identification
of the covalent interactions of these drugs in an environ-
ment more closely resembling that of chromosomal DNA
as packaged in the nucleus of living cells is particularly rel-554 Chemistry & Biology 14, 553–563, May 2007 ª2007 Elsevievant. A previous study revealed a decrease in the levels
of MMC-mediated interstrand crosslinking on nucleoso-
mal DNA when compared to free DNA [26]; however,
MMC-mediated monoalkylation on linear versus nucleo-
somal DNA could not be demonstrated conclusively.
Furthermore, the effects of DNA crosslinking on transcrip-
tion and chromatin assembly have not been investigated
in detail.
Here, we describe the effect of a photochemically acti-
vated NVOC derivative (5, Figure 1) on two distinct free
and nucleosomal DNA templates that are both 146 bp in
length. Apart from base composition, the templates differ
in the number and location of 50CpG30 steps (Figure 2). We
investigated the ability of 5 to crosslink or alkylate free and
nucleosomal DNA. We observed a dramatic decrease in
crosslinking of nucleosomal DNA and a commensurate
increase in monoalkylation. Compound 5 significantly in-
hibits in vitro transcription and nucleosome assembly.
Our studies conclude that crosslinking of free DNA medi-
ated by 5may affect cellular proliferation by targeting two
vital processes—chromatin assembly and transcription.er Ltd All rights reserved
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The Effects of Alkylating Agents on ChromatinFigure 2. The Two DNA Fragments Differ in the Number and Location of 50CpG30 Dinucleotide Steps
(A) Sequence of the two DNA fragments under investigation. The asymmetric 5S DNA template contains nine 50CpG30steps (pink); the palindromic
a-satellite DNA contains a single 50CpG30step (green).
(B) Representation of a target site in a structural context. The left and middle panels represent the two halves of the 5S DNA (5S NCP [R] and [L],
respectively); the dyad is indicated as 0. The numbers ± 1–7 represent the superhelical axis location (SHL) of nucleosomal DNA. Since the structure
of the 5S NCP is not known, we show a projection of the target sites onto the structure of the a-satellite NCP as a model. The right-most panel is
a graphical representation of the compound 5 target site on a-satellite nucleosomal DNA. The arrows indicate the location of the symmetry dyad.RESULTS
Nucleosomal DNA Is Crosslinked Inefficiently
by Compound 5 Compared to Free DNA
The preference of mitosene-based drugs for 50CpG30 di-
nucleotide steps results from the favorable geometric
arrangement of the electrophilic sites of the drug and the
target sites on linear B form DNA (Figure 1). Nucleosomal
DNA, although still classified as B form, is distorted com-
pared to unassembled DNA due to the high degree of
bending upon superhelix formation [25]. To test the effect
of this distortion on the efficiency of crosslinking, we com-
pared two different 146 bp DNA sequences in the context
of highly positioned nucleosomes—a palindromic DNA
fragment derived from human a-satellite DNA and an
asymmetric fragment derived from the Xenopus laevis
5S rRNA gene. While the former has been used routinely
to generate homogeneous nucleosome species mainly for
crystallization purposes (reviewed in [27]), the latter has
been used extensively for biochemical analyses. The two
sequences differ significantly in the number and location
of 50CpG30 steps (Figure 2).
Free DNA and assembled nucleosomes (5S and a-sat-
ellite nucleosome core particle [NCP]) that had beenChemistry & Biology 14,separated from any remaining free DNA by preparative
gel electrophoresis were treated with 5 and were ana-
lyzed by native PAGE for the presence of free DNA (Fig-
ures 3A and 3B). Even at a 60-fold molar excess of 5,
nucleosomes remained intact and exhibited no release
of free DNA. DNA was isolated from nucleosomes, and
the degree of crosslinking in free and nucleosomal DNA
was analyzed by alkaline agarose electrophoresis (Fig-
ures 3C–3F). The percentage of crosslinks as a function
of molar excess of drug is plotted in Figure 3G. As
expected from the differences in the number of 50CpG30
sites on a-satellite DNA compared to 5S DNA (1 versus 9
in each 146 bp DNA fragment, Figure 2), free 5S DNA
is crosslinked much more efficiently than free a-satellite
DNA (Figure 3C versus Figure 3D, respectively). In both
cases, the level of crosslinking is reduced significantly
in nucleosomes (Figures 3E and 3F for 5S NCP and
a-satellite NCP, respectively), indicating that the inher-
ent distortions in nucleosomal DNA and the partial
protection by histones inhibit the formation of interstrand
crosslinks.
Similar experimentswerealsoperformedwith theFK317
compound (4, Figure 1). The rate of FK317-mediated
modification was exceedingly slow, requiring as long as553–563, May 2007 ª2007 Elsevier Ltd All rights reserved 555
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The Effects of Alkylating Agents on ChromatinFigure 3. Reduced Crosslinking Medi-
ated by the NVOC Derivative 5 on Nucle-
osomal DNA
(A and B) NCPs reconstituted with 5S DNA and
a-satellite DNA, respectively, treated with in-
creasing molar ratios of NCP:compound 5.
The samples were analyzed on a 5% native
PAGE gel stained with ethidium bromide to de-
termine any appearance of free DNA due to
compound 5-induced NCP dissociation. Lane
1 in (A) and (B) indicates free DNA, while lane
2 in both panels shows NCP controls without
the drug. Lane 3 shows NCP treated with UV
radiation without the drug, while lanes 4–8
show 1:1, 1:10, 1:20, 1:40, and 1:60 ratios, re-
spectively, of NCP:compound 5 in both panels.
(C–F) (C) and (D) show denaturing alkaline aga-
rose gels of 5S and a-satellite DNA treated with
increasing ratios ofNCP:compound 5. Lane 1 in
both panels shows untreated DNA, while the
DNA in lanes 2–8 was treated with 1:1, 1:5,
1:10, 1:20, 1:40, 1:60, and 1:80 molar ratios,
respectively, of NCP:compound 5. (E) and (F)
show denaturing alkaline agarose gels of 5S
and a-satellite nucleosomal DNA treated with
increasing ratios of NCP:compound 5. Lane 1
in both panels represents untreated DNA,
while lanes 2–8 represent 1:1, 1:5, 1:10, 1:20,
1:40, 1:60, and 1:80 ratios, respectively, of
NCP:compound 5. The alkaline agarose gels
were stained and visualized with Sybr Gold,
and the intensity of the crosslinked and uncros-
slinked bands was determined by using the
Image Quant Analysis (version 5.1) software.
(G) Graphical representation of the efficiency of
compound 5-mediated crosslinking on DNA/
nucleosomal a-satellite and 5S DNA. The effi-
ciency of crosslinking was determined from
the ratio of the intensity of the crosslinked
band to the sum of the intensities of the cross-
linked and uncrosslinked bands, and values
thus obtained were plotted as compound 5-
mediated percentage crosslinking as a function
of the fold excess of compound 5 (over DNA/
nucleosomal DNA).3 months after activation of the drug to obtain detectable
levels of crosslinking on free 5S DNA. No detectable levels
of crosslinkswere observed on either 5SNCPor unassem-
bled and assembled a-satellite DNA (data not shown).
Since the integrity of nucleosome samples for such ex-
tended periods of time was uncertain, further studies
with this compound were deemed impractical.
Alkaline agarose gel electrophoresis allows us to distin-
guish between crosslinked and uncrosslinked species,
but it does not possess the resolution to visualize monoal-
kylation. In contrast, denaturing PAGE allows for good
resolution of the unmodified, single-stranded DNA; mono-
alkylated, single-stranded DNA; and crosslinked DNA
strands. Figure 4A shows the analysis for free and nucleo-
somal a-satellite DNA. A crosslinked DNA control, purified
from a denaturing gel, was loaded as a control (Figure 4A,
lane 2). The gel was scanned, and the percentage of cross-
linked DNA obtained by this method was compared to the
numbers plotted in Figure 3G. The numbers obtained for556 Chemistry & Biology 14, 553–563, May 2007 ª2007 Elseviera 40-fold molar excess of compound 5 (1.2% and 14%
for nucleosomal and free a-satellite DNA, respectively)
compared well to numbers plotted in Figure 3G (4.5%
and 11%, respectively).
Even though the a-satellite DNA template has only one
50CpG30 site (Figure 2), two bands are visible in Figure 4A
upon incubation with compound 5. Although we cannot
exclude the possibility that these represent adducts
formed at other sites, we surmised that these may repre-
sent positional crosslinked isomers. These isomers may
be formed due to the difference in orientation of the reac-
tive mitosene residue in the 50CpG30 step, which is largely
dependent on which of the reactive centers on the mito-
senemoiety reacts with the exocyclic N2 amine on guano-
sine [18]. The nucleosomal template has a much higher
abundance of the monoadduct than free DNA, demon-
strating that nucleosomal DNA is preferentially monoalky-
lated. Since only a single monoalkylated species is appar-
ent, we suggest that the sequence preference for 50CpG30Ltd All rights reserved
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The Effects of Alkylating Agents on ChromatinFigure 4. Preferential Compound 5-Me-
diated Monoalkylation of Nucleosomal
DNA Compared to Linear DNA
(A–C) Urea-8% polyacrylamide gel (8%
DPAGE) analysis was conducted on
[g-32P]ATP nucleosomal and free DNA. (A)
DPAGE analysis on compound 5-treated a-
satellite DNA/nucleosomal DNA. Lane 1, a-sat-
ellite DNA; lane 2, crosslinked a-satellite DNA
control. The two different orientation isomers
are illustrated at the side of the gel. Lanes 3
and 4, a-satellite DNA treated with a 20 and
40 molar excess, respectively, of compound
5 to DNA. Lane 5, nucleosomal a-satellite
DNA treated with Proteinase K; lanes 6 and 7,
nucleosomal DNA treated with 20 and 40molar
excess, respectively, of compound 5. (B)
DPAGE analysis of free 5S DNA. Lane 1, 5S
DNA. The two bands correspond to the differ-
ence in charge, and hence migration, of the
two complimentary strands of 5S DNA. Lanes
2 and 3, 5S DNA treated with 20 and 40 molar
excess, respectively, of compound 5. (C)
DPAGE analysis of 5S nucleosomal DNA.
Lane 1, nucleosomal 5S DNA treated with Pro-
teinase K; lanes 2 and 3, nucleosomal 5S DNA
treated with 20 and 40 molar excess, respec-
tively, of compound 5. The concentration of
DNA used in these reactions was 6.25 mM,
and that of the nucleosomes was 12.5 mM.may be maintained in the context of the nucleosome even
for monoalkylation by 5.
The same experiment was repeatedwith 5SDNA, which
contains nine (as opposed to one) 50CpG30 sites. No signif-
icant monoalkylated species were observed on free 5S
DNA at a 40-fold molar excess of drug (Figure 4B, lane
3). Instead, we observed a family of multialkylated prod-
ucts whose migration rates are slower than the monoad-
duct species, but faster than the more prominent cross-
linked species. Nucleosomal 5S DNA treated with similar
amounts of 5 is predominantly multialkylated, whereas
crosslinks are barely visible (Figure 4C, lanes 2 and 3).
We conclude that the NVOC derivative 5 is bifunctional
and can cause both interstrand DNA crosslinking as well
as alkylation. The outcome apparently depends entirely
on the conformational state of the DNA.
The presence of monoalkylated DNA raises the intrigu-
ing possibility that histones may become crosslinked to
DNA upon treatment with 5. However, preliminary assays
in which dissociation of nucleosomes in response to salt
was measured showed no difference between untreatedChemistry & Biology 14,and 5-treated nucleosomes, indicating that no protein-
DNA crosslinks were formed. This was not entirely unex-
pected since the distances between lysines and DNA ba-
ses in the nucleosome structure are too large for effective
crosslinks. However, more careful analysis is required to
exclude the possibility of drug-mediated histone-DNA-
induced crosslinks.
Compound 5-Mediated Crosslinking of
Unassembled DNA Represses In Vitro Transcription
Histones are transiently removed from DNA during tran-
scription, often with the help of ATP-dependent chroma-
tin-remodeling factors and perhaps also histone chaper-
ones [28, 29]. This generates a window of opportunity
for efficient crosslinking of nucleosome-free DNA bymito-
sene-based drugs. To investigate the effect of crosslink-
ing on basal and activated transcription, we employed a
previously established in vitro system [30, 31] that utilizes
a well-characterized plasmid template (p4TxRE/G-less).
The plasmid contains 178 50CpG30 dinucleotide steps
that are distributed quite uniformly along its entire length,553–563, May 2007 ª2007 Elsevier Ltd All rights reserved 557
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The Effects of Alkylating Agents on ChromatinFigure 5. Decreased Levels of In Vitro
Transcription from Crosslinked DNA
Templates
(A) In vitro transcription assay indicating a de-
crease in transcript levels only in the presence
of compound 5-mediated crosslinked product.
The asterisk indicates activated compound 5.
Each transcription reaction contains 150 ng
p4TxRE template and 60 mg nuclear extract-
CEM from HTLV-negative human T cells. A to-
tal of 100 ng purified recombinant Tax and
100 ng purified recombinant CREBwere added
to the reaction where indicated.
(B) Quantitation of the transcript levels was
performed by using Image Quant Analysis (ver-
sion 5.1) software, and the relative transcript
levels were normalized to the highest Tax and
CREB activation. The shaded bars represent
those reactions activated by Tax and CREB.
The fold increase in transcription levels due to
this activation (compared to the corresponding
basal transcription levels, empty bars) is indi-
cated above each of these bars. The error
bars represent the deviation from the average
transcript levels obtained from three indepen-
dent experiments.with the exception of the 380 bp G-less cassette. We
made use of an in vitro assembly system consisting of pu-
rified assembly factors that recapitulates many aspects of
in vivo chromatin assembly [30].
Transcript levels were monitored under basal and acti-
vated conditions in the absence and presence of the co-
activators Tax and CREB [32]. To account for variations
in the recovery of transcripts, each reaction was normal-
ized against a recovery standard (see Experimental Pro-
cedures). Under both conditions, the crosslinked template
showed a significant reduction in transcription levels when
compared to a control that had not been activated by light.
Figure 5B is a quantitative representation of the data
shown in Figure 5A. Basal transcript levels from cross-
linked DNA template decreased 5-fold compared to un-
treated template. Activated transcript levels dropped
25-fold when compared to the transcript levels of the
inactive-compound 5 reaction.
Compound 5-Mediated Crosslinking of Plasmid DNA
Reduces the Efficiency of Chromatin Assembly
Mitosene-based drugs are particularly effective in rapidly
dividing cancer cells, where DNA synthesis and concom-
itant chromatin assembly are frequent events. We there-
fore wanted to quantify the effect of DNA crosslinking558 Chemistry & Biology 14, 553–563, May 2007 ª2007 Elsevand alkylation on the efficiency of in vitro chromatin as-
sembly. The same p4TxRE/G-less templates (untreated
and treated with compound 5) that were used for the
in vitro transcription assay described above were em-
ployed for this assay.
The plasmid was treated with a 40-fold molar excess of
compound 5 prior to assembly to ensure complete satura-
tion of all available sites. Crosslinking was verified by line-
arizing the plasmid, followed by analysis by alkaline gel
electrophoresis (data not shown). Crosslinked plasmid
was purified from unreacted DNA and free 5 by gel elution
under native conditions, exploiting the fact that cross-
linked plasmid exhibits a slower electrophoretic mobility
than untreated plasmid (data not shown). Untreated and
5-treated supercoiled plasmids were assembled into
chromatin by using the purified chromatin-remodeling
factor ACF1 and the histone chaperone dNAP-1 [33].
The assemblies were assayed by micrococcal nuclease
(MNase) digestion and Quantitative Agarose Gel Electro-
phoresis (QAGE)-Multigel Analysis.
MNase digestion confirmed that the nucleosomes re-
constituted onto untreated DNA template are spaced, on
average, 165–170 bp apart (Figure 6A, lanes 2–5). Interest-
ingly, chromatin assembled on 5-treated plasmid DNA
was resistant toward digestion with MNase, whereas noier Ltd All rights reserved
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The Effects of Alkylating Agents on Chromatineffect was found if the plasmid was treated with light in the
absence of 5. A DNA band corresponding tomononucleo-
somes was visible only at the highest MNase con-
centrations (Figure 6A, lane 15). This could be due to the
fact that crosslinked DNA is a poor substrate for most
nucleases [33]. This was addressed in a control experi-
ment in which the effect of 5 treatment on the sensitivity
of unassembled plasmid DNA to digestion with MNase
was assayed (Figure 6A, right panel). Whereas untreated
DNA is digested rapidly and without a trace, crosslinked
plasmid DNA exhibited increased resistance toward
digestion.
The results shown in Figure 6A raise the possibility that
chromatin assembly is inefficient on a crosslinked DNA
template. To further investigate this, we used QAGE-
Multigel Analysis, a method that has been used success-
fully in the past for the analysis of chromatin to determine
parameters such as average surface charge density and
particle deformability [34, 35]. More precisely, this method
allows us to quantitate the average surface charge density
of unassembled DNA and assembled DNA, thus effec-
tively ‘‘counting’’ the number of nucleosomes on any given
DNA fragment. The same analysis was also performed
with the free DNA sample. A typical example is shown in
Figure 6B. Ferguson plots (semilogarithmic plots of migra-
tion distance, m, versus agarose percentage; Figure 6C)
allow for the determination of mo and mo
0. The mo0 values
for all of the species in Figure 6 are listed in Table 1. Cross-
linked DNA species and the untreated DNA species do not
vary significantly in their mo
0 values. This demonstrates that
there are no differences in surface charge densities in the
free DNA upon treatment with compound 5. This not only
validates the technique, but also establishes the fact that
any change in nucleosome assembly on the 5-treated and
untreated plasmid is not associated with charge.
The mo
0 values listed in Table 1 were used to calculate
the number of nucleosomes assembled on the two tem-
plates [34, 35]. This analysis shows that an average of
18.5 nucleosomes are assembled on the untreated
p4TxRE/G-less plasmid. On 3245 bp, this converts to a re-
peat length of 175 bp, a number that corresponds well to
the repeat length established by MNase (Figure 6A, left
panel). On crosslinked DNA, an average of 14.5 nucleo-
somes was assembled. This 22% reduction in the number
of nucleosomesassembledon the5-treatedDNA template
when compared to an untreated DNA template is repro-
ducible and indicates that crosslinking indeed has an in-
hibitory effect on chromatin assembly under physiological
conditions.
DISCUSSION
Bioreductive alkylating agents are an important class of
anticancer drugs that act through their ability to covalently
crosslink two strands of DNA, thus impeding DNA replica-
tion of rapidly dividing cancer cells. The synthetic NVOC
derivative (5) is a photoactivated compound that gener-
ates in high chemical yield a doubly electrophilic mitosene
species that is structurally and mechanistically homolo-Chemistry & Biology 14, 5gous to the mitosenes generated by bioreductive activa-
tion of FK317, MMC, and congeners. Here, we showed
that interstrand crosslinking of nucleosomal DNA by com-
pound 5 is suppressed, while, at the same time, the extent
of monoalkylation markedly increases. Our finding that
crosslinked DNA is inefficiently transcribed and assem-
bled into chromatin suggests additional mechanisms
by which mitosene-based drugs display their cytotoxic
effect.
It has been shown previously that the efficiency of
MMC-induced crosslinking on nucleosomes, compared
to free DNA, was reduced [26]. In the present study, we
have significantly extended this finding by demonstrating
the preferential formation of monoalkylated over cross-
linked products at the nucleosomal dyad. Nucleosomal
DNA is distinct from unassembled DNA in its helical pa-
rameters [25]. The exact geometry of each given CpG
step depends on its rotational and translational position
with respect to the histone octamer. By using nucleo-
somes assembled on a-satellite DNA, we have the oppor-
tunity to directly measure the distance between the reac-
tive centers of the only CpG step that is located near the
nucleosomal dyad [36]. The distance measured between
the two opposing exocyclic amine residues in the minor
groove at this particular location in the nucleosome is
3.95 A˚, whereas the distance between the same reactive
centers on unassembled B form DNA is 3.4 A˚. This 0.5 A˚
difference is significant in light of the estimated distances
between reactive centers in other dinucleotides that are
not crosslinked on B form DNA. For example, the distance
between the targets sites in a GpG step is 4.2 A˚, and in
a GpC step it is 4.6 A˚.
Apparently, nucleosomal DNA is too structurally con-
strained to allow formitosene-mediated interstrand cross-
linking. Instead, monoalkyation at presumably the same
site is observed. What then is the biological significance
of mitosene-mediated alkylation of nucleosomal DNA? Al-
kylation has been considered a less cytotoxicmodification
compared to interstrand DNA crosslinking, as it is easily
corrected by the nucleotide base-excision repair machin-
ery [2, 3]. However, it remains to be investigated how effi-
ciently this type of damage is repaired in the context of
chromatin. Monoalkylation has also been proposed as
a suitable intermediate for the formation of crosslinks. Ear-
lier studies have shown that congener FR66979 can cause
protein-DNA crosslinks via drug-mediatedmonoalkylation
of DNA and the oncoprotein HMG A1 in vitro [37]. Similar
crosslinks were observed in vivo upon treatment with
FR900482 and FK317 [38]. This leads to the interesting
hypothesis that monoalkylation of nucleosomal DNA, es-
pecially at the nucleosomal dyad, could result in the cross-
linking of chromatin-associated protein to nucleosomal
DNA, which could have far-reaching implications on chro-
matin dynamics and DNA accessibility.
About 80% of all eukaryotic DNA is organized in nucle-
osomes, leaving only parts of the linker DNA and the occa-
sional highly active promoter histone free. The processes
of replication, transcription, and DNA repair require tran-
sient exposure of DNA [39, 40]. This may represent53–563, May 2007 ª2007 Elsevier Ltd All rights reserved 559
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The Effects of Alkylating Agents on ChromatinFigure 6. Crosslinking of DNA Affects the Efficiency of Chromatin Assembly
(A) Qualitative analysis of the assembled template by micrococcal nuclease digestion. The various templates used in these analyses are indicated
above the lanes. The left panel represents the micrococcocal nuclease digestion on chromatin templates at different time points (1, 2, 4, and 8
min, respectively). The right panel represents the micrococcal nuclease digestion analyses on untreated and compound 5-treated p4TxRE. Lanes
2, 8, and 14 represent untreated p4TxRE, p4TxRE treated with 20 molar excess compound 5, and p4TxRE treated with 40 molar excess compound
5, respectively. Lanes 3–6, 9–12, and 15–18 represent the digestion times of 0.5, 1, 2, and 4 min, respectively.
(B) The right and left panels represent the QAGE analyses performed on untreated p4TxRE/assembled p4TxRE and compound 5-treated p4TxRE/
assembly with crosslinked p4TxRE, respectively. The numbers over each lane indicate the agarose concentrations.
A qualitative representation of these data is shown in Table 1.560 Chemistry & Biology 14, 553–563, May 2007 ª2007 Elsevier Ltd All rights reserved
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The Effects of Alkylating Agents on Chromatina window of opportunity for mitosene-derived drugs to
crosslink the two strands of DNA. This modification is
likely to be refractory to all processes that require melting
of the DNA double helix. Our studies show that basal as
well as activated transcription from crosslinked DNA tem-
plates is severely impaired. This defect stems from the
inability of the polymerase to initiate transcription, since
the G-less cassette is free of crosslinks.
The potential effect of DNA crosslinking on chromatin
assembly has largely been ignored in investigations of the
mechanisms of mitosene-based cytotoxicity. Using a de-
fined in vitro assembly system, we found a 22% decrease
in nucleosome occupancy on a crosslinked template. The
majority of chromatin is assembled during S phase, during
which the histones are deposited on the newly replicated
DNA by Chromatin Assembly Factor-1 (CAF-1) [41]. Sup-
pression of the p60 subunit of CAF-1 by RNAi results in
a slightly reduced efficiency of chromatin assembly [42].
These cells exhibited cell-cycle arrest and programmed
cell death. Thus, it appears that a relatively small decrease
in assembly could be a sufficient signal to induce cell-
cycle arrest in S phase, especially in rapidly dividing cells.
Since posttranscriptional chromatin assembly is also a
key process for quiescent cells, it is possible that mito-
senes may be toxic for nondividing cells through these
mechanisms.
To our knowledge, these studies reveal new and hith-
erto unresolved possible mechanisms to explain how mi-
tosene-based antitumor agents may exert their cytotoxic
effect in rapidly proliferating cells. We are continuing to
study themolecular interactions of such agents in the con-
text of dynamic processes of chromatin assembly, and
there remains the possibility for the formation of additional
covalencies between the DNA-bound drug and histones
as well as other proteins closely associated with the com-
plex processes of replication and transcription.
Table 1. Quantitative Analysis of Chromatin Assembly
via Multigel Analysis
Samples
mo cm
2/V/s
(3104)
Number of
Nucleosomes
p4TxRE/G-less 2.27635
Assembled
p4TxRE/G-less
1.6764 18.5 ± 2
Compound 5-treated
p4TxRE/G-less
2.47647
Assembled,
compound 5-treated
p4TxRE/G-less
1.9661 14.5 ± 1
The number of nucleosomes was calculated as described in
Experimental Procedures. Experiments were repeated three
times.Chemistry & Biology 14,SIGNIFICANCE
This study has been able to emphasize the differential
activity of the phototriggered NVOC derivative on con-
formationally distinct unassembled and assembled
DNA. The bifunctional activity of compound 5 seems
to be dependent on the conformation of the DNA tem-
plate. We believe that this finding will help provide
insight into the design of a specific alkylating agent
based on the contours of nucleosomal DNA and hence
into its effective use as an anticancerous agent.
This study has also shown conclusively the effect of
compound 5-mediated interstrand crosslinking on
transcription and chromatin assembly.Webelieve that
this is the first time the quantitative effect of crosslink-
ing on both of these functional processes has been
demonstrated. This could be a major step in under-
standing one of the many levels at which these DNA
crosslinking agents act to decrease and disrupt cellu-
lar replication, and hence behave as effective antican-
cerous drugs.
EXPERIMENTAL PROCEDURES
Drug Stock Solution
Compound 5 was prepared according to published procedures [23]. A
stock solution of 10 mg/ml (15.8 mM) 5 was prepared in 100% DMSO
and placed in a light-safe tube to prevent photodecay. Appropriate
dilutions were made in 100% DMSO.
Nucleosome Preparation
The 146 bp 5S and a-satellite DNA templates were prepared as pub-
lished [43], and the corresponding nucleosomes were reconstituted
by using recombinant full-length Xenopus histone octamer via salt
dialysis as described earlier [27].
DNA Crosslinking and Alkaline Agarose Electrophoresis
The final volume of the crosslinking reaction was 20 ml. The final con-
centration of free DNA (both 5S and a-satellite) in these reactions
was 6.25 mM, and it was 12.5 mM for nucleosomal DNA. The samples
were irradiated in clear Eppendorf tubes at 25C for 1 hr with an ultra-
violet lamp (Rayonet) containing 350 nm bulbs [23, 44] and incubated
in the dark at 4C. Excess drug was removed from free DNA samples
by ethanol precipitation. In order to remove excess drug and histones
from compound 5-treated nucleosomal samples, the 20 ml reaction
mixture was treated with 5.2 ml 4M NaCl, 4 ml 20 mg/ml glycogen,
and 60 ml 100% ethanol. The nucleosomes were then pelleted by spin-
ning the samples at 13.2 K rpm for 30 min. Histones were removed by
Proteinase K treatment in a volume of 100 ml containing a final concen-
tration of 0.1 mg/ml Proteinase K (Sigma-Aldrich). The samples were
incubated at 37C for at least 1 hr, followed by phenol chloroform ex-
traction and ethanol precipitation. All samples (both nucleosomal and
free DNA) were analyzed by 1.4% alkaline agarose electrophoresis
[45]. The gels were run at 75 V for 50–55 min and stained with SyBr
Gold (Invitrogen, Molecular Probes). The appropriate bands were
quantified by using Image Quant Analysis (version 5.1) software.(C) The QAGE results are represented quantitatively in a Ferguson Plot. The y axis has been set to logarithmic scale. Intact T3 phage was used as
a migration control as well as in determination of the unknown mo value for unassembled and assembled DNA. The plot is first used to determine
the gel-free mobility (mo0) [35]. The values obtained in these plots are listed in Table 1.553–563, May 2007 ª2007 Elsevier Ltd All rights reserved 561
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Free and nucleosomal DNA samples were subjected to treatment with
compound 5, and DNA was isolated from nucleosomes as described
above. A total of 10 mg extracted DNA was radiolabeled at the 50 end
with [g-32P]ATP by following standard protocols in a final volume of
50 ml and in the presence of T4 polynucleotide kinase (NEB). The radio-
labeled DNA was then subjected to phenol-chloroform extraction and
ethanol precipitation to remove enzyme and excess radiolabel in the
reaction mix. The resulting samples were analyzed by 8% PAGE in
the presence of urea [44]. The gel was first prerun at 30 W for about
30 min (until the temperature of the gel was 50C), and then run at
30 W for 40 min in 13 TBE buffer. The gel was dried and exposed to
a Phosphorimager screen for 10–15 hr. The screen was then scanned
and visualized with Image Quant Analysis (version 5.1) software.
In Vitro Chromatin Assembly
The p4TxRE/G-less plasmid template, nativeDrosophila core histones,
recombinant ACF, and dNAP1 were purified as described [30]. The
in vitro assemblies were performed as described in [30]. The standard
chromatin assembly reaction was 98 ml and contained 2.1 mg plasmid
DNA (0.994 pmoles 3.2 kp plasmid DNA), 1.505 mg purified native
Drosophila core histones (0.11 nmoles of each histone), 12.012 mg
purified recombinant dNAP1 (0.2145 nmoles dNAP1 monomer), and
0.36 mg purified recombinant Drosophila ACF (1.285 pmoles ACF pep-
tide), in 10mMHEPES (pH 7.6), 50 mMKCl, 5 mMMgCl2, 5% glycerol,
1% PEG, 3 mM ATP, 0.01% NP40, an ATP-regenerating system (30
mM phosphocreatinine and 1 mg/ml creatinine phosphokinase), and
140ngBSA. The reactionwasperformedat 27C for 4–12hr.Micrococ-
cal nuclease digestion was performed as described [46].
Quantitative Agarose Gel Electrophoresis-Multigel Analysis
To determine the number of assembled nucleosomes, the average
surface charge density of unassembled and assembled DNA template
had to be quantitated [34]. The mobility of the species (m) was calcu-
lated as a function of the agarose concentration in electrophoresis per-
formed on nine gels, each of different concentrations, between 0.2%
and 1.0%, of agarose, embedded in a 1.5% agarose frame and run at
1 V/cm. The values of mo
0 (gel free mobility) and mo (mo0 corrected for the
electro-osmotic effects of the buffer) were estimated as described [35].
In this study, the 18-lane template was used to run unassembled DNA
with its corresponding assembled species in the same gel frame. Both
the frame and running gel were cast in TAE buffer (40 mM Tris acetate,
1 mM EDTA [pH 7.8]) or E Buffer (40 mM Tris-HCl, 0.25 mM EDTA [pH
7.8]) as indicated, and the corresponding EEO (electroendoosmosis)
values were used to calculate mo. The assembly reaction containing
2.1 mg assembled DNA alongwith 1 mg intact T3 phage (migration stan-
dard) was loaded such that 0.23 mg assembled DNA was present in
each well. The same amount of supercoiled unassembled DNA was
loaded along with the T3 control. The gels were run at room tempera-
ture (48 V for 6 hr), with running buffer circulating for the duration of the
experiment. With the mo values thus obtained for unassembled and
assembled DNA templates, the number of assembled nucleosomes
was calculated as reported [34, 35].
The p4TxRE/G-less plasmid was treated with compound 5 in a man-
ner similar to that of unassembled DNA, asmentioned previously in the
same section.
In Vitro Transcription Assay
The in vitro transcription assay was carried out in a final reaction vol-
ume of 30 ml containing 1 mM acetyl CoA, 150 ng DNA (treated or un-
treated as mentioned), and 70 mg CEM (HTLV-negative human T cells).
For activated transcription reactions, the same conditions were used
alongwith 100 ng Tax and 100 ngCREB. The reactionswere incubated
at 30C for 1 hr. The samples were then incubated with 250 mM ATP,
250 mM CTP, 12 mM UTP, and 0.8 mM [a-32P]UTP (3,000 Ci/mmol) for
30 min at 30C. This allows for transcription through the 380 nt G-
less cassette in the p4TxRE/G-less plasmid [31]. The readthrough tran-
scripts were cleaved after treating these reactions with RNase T1 (100562 Chemistry & Biology 14, 553–563, May 2007 ª2007 ElsevU/reaction) at 37C for 30 min. RNase T1 is an endoribonuclease that
specifically degrades single-stranded RNA at the G residues. This en-
zyme is therefore extremely useful for detection of RNA transcript
levels from DNA templates containing the G-less cassette. The reac-
tion was terminated by addition of 123 mM NaCl, 0.5% SDS, and 2.5
mM EDTA, and the samples were subjected to Proteinase K treatment
at 50C for 30 min. The transcripts were then extracted via precipita-
tion with a final concentration of 0.48 M ammonium acetate and 0.3
mg/ml carrier tRNA. In this step, an appropriate amount of radiolabeled
DNA fragment was added as a recovery standard. The precipitated
samples were analyzed on a urea-6.5% polyacrylamide gel. The gel
was subsequently dried and visualized by Image Quant Analysis (ver-
sion 5.1) software. The software was used to quantitate the transcript
yields under the various conditions indicated. The transcript levels in
each lane were normalized against the recovery standard (internal
control). The highest signal (due to activation with Tax and CREB)
was assigned the number 1, and all the other normalized transcript
levels were then represented as fractions of the highest value.
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